Steward Partners Investment Advisory’s Achieve Life Sciences ACHV Stock Holding History

Steward Partners Investment Advisory’s Portfolio ACHV Stock Details ACHV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$632	Sell	215 -4,425	-95%	-$19.6K	﹤0.01%	4243
2025 Q4	$23.1K	Buy	+4,640	New	+$20.2K	﹤0.01%	3080
2020 Q1	–	Sell	-176	Closed	-$1K	–	2467
2019 Q4	$1K	Buy	+176	New	+$3.77K	﹤0.01%	2480

Other funds holding ACHV

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Steward Partners Investment Advisory's ACHV Position: Q1 2026 in Review

Steward Partners Investment Advisory reduced its Achieve Life Sciences (ACHV) stake by 95% in Q1 2026, selling an estimated $19.6K and leaving 215 shares worth $632. The position accounts for ﹤0.01% of the portfolio, ranked #4243.

Steward Partners Investment Advisory first reported a position in ACHV in Q4 2019 and has held it in 3 quarters since. The position peaked at $23.1K in Q4 2025. 81 funds tracked by Wall St. Rank hold ACHV as of Q1 2026.

Steward Partners Investment Advisory held 215 shares of Achieve Life Sciences worth $632 as of Q1 2026.
Steward Partners Investment Advisory sold 4,425 Achieve Life Sciences shares in Q1 2026, an estimated $19.6K.
Achieve Life Sciences made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q1 2026, its #4243 holding.
Steward Partners Investment Advisory first reported a position in Achieve Life Sciences in Q4 2019 and has held it in 3 quarters since.
Steward Partners Investment Advisory's Achieve Life Sciences position peaked at $23.1K in Q4 2025.
81 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q1 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.